Accessibility navigation


What GPs need to know about palliative-care drugs: ketamine

Howard, R. L. and Howard, P. D. (2012) What GPs need to know about palliative-care drugs: ketamine. Prescriber, 23 (12). pp. 43-46. ISSN 0959-6682

Full text not archived in this repository.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.1002/psb.933

Abstract/Summary

This is the first in a short series of articles that focus on what GPs should consider when monitoring and prescribing specialist-initiated palliative-care drugs. This first article summarises the key issues for patients receiving ketamine.

Item Type:Article
Refereed:Yes
Divisions:Faculty of Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy > Pharmacy Practice Research Group
ID Code:28907
Publisher:Wiley

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation